(1 - 7 von 7
)
COMUNICADO: Novocure(TM) anuncia la publicación de un nuevo...
www.europapress.es
... Choice Chemotherapy [http://www.seminoncol.org/article/S (14) abstract]Andrew A. Kanner, Eric T. Wong, John L. Villano, ...
Novocure wird auf dem 4. Vierjahrestreffen der World Federation of...
www.ots.at
Eine aktualisierte Untergruppenanalyse der Daten aus Phase III.Präsentator : Andrew Kanner, Tel Aviv Sourasky Medical Center, Israel. Poster:
Next events
brazilianlifesciences.com
Andrew A. Kanner, Eric T. Wong, John L. Villano, Zvi Ram, on behalf of EF-11 Investigators. Alternating Electric Fields (Tumor Treating Fields Therapy) Can ...
COMUNICADO: Novocure presenta 15 abstractos que describen los últimos...
www.europapress.es
Presenter: Andrew Kanner, Tel Aviv Sourasky Medical Center, Israel. Póster: NO The effect of field strength on GBM response in patients ...
American Academy of Neurology and American Ep | EurekAlert!
www.eurekalert.org
To contact Andrew Kanner, M.D., contact John Pontarelli at or . On the day of the briefing, call the AMA's ...
History of Changes for Study: NCT
clinicaltrials.gov
Andrew Kanner, MD Principal Investigator Tel Aviv Medical Center. Matthias Pruesser, MD Principal Investigator University of Vienna. Andrea Salamaggi, MD
Medipost - Autumn | Ichilovwww.tasmc.org.il › Donations › Newsletter › Pages
www.tasmc.org.il
Dr. Andrew Kanner, Director of the Stereotactic Radiosurgery Service, launched the Stereotactic Radiosurgery Outpatient Unit to complement the ...
sortiert nach Relevanz / Datum